The completion of the first Phase 2a clinical trial for SYN-004 is an important achievement for Synthetic Biologics

7 Dec
The completion of the first Phase 2a clinical trial for SYN-004 is an important achievement for Synthetic Biologics

Biological products are commonly used or genetically engineered, cell engineering, protein engineering, fermentation engineering and other biological technology to obtain microbial cells and various animal and human sources of tissue and liquid and other biological materials, for human disease prevention, … Read More »